MEDIMMUNE VENTURES

MedImmune Ventures invests in early to late stage, public and private biotechnology companies.

#People #Financial #More

Twitter

Biotechnology Financial Services Venture Capital

1987-01-01

Closed

[email protected]

Rackspace CSC Global DNS Cvent

ron-laufer_image

Ron Laufer
Ron Laufer Senior Managing Director @ MedImmune Ventures
Senior Managing Director

tyrell-rivers_image

Tyrell Rivers
Tyrell Rivers Senior Associate @ MedImmune Ventures
Senior Associate
2009-10-01

not_available_image

Franklin H. Top
Franklin H. Top Vice President @ MedImmune Ventures
Vice President

Date	Company	Article	Money raised
2016-05-11	G1 Therapeutics	MedImmune Ventures investment in Series C - G1 Therapeutics	47 M USD
2015-02-05	G1 Therapeutics	MedImmune Ventures investment in Series B - G1 Therapeutics	33 M USD
2014-09-23	VentiRx Pharmaceuticals	MedImmune Ventures investment in Series B - VentiRx Pharmaceuticals	50.6 M USD
2013-11-14	Astria Therapeutics	MedImmune Ventures investment in Series B - Astria Therapeutics	32.4 M USD
2013-10-16	G1 Therapeutics	MedImmune Ventures investment in Series A - G1 Therapeutics	12.6 M USD
2013-09-27	Inotek Pharmaceuticals	MedImmune Ventures investment in Venture Round - Inotek Pharmaceuticals	21 M USD
2013-09-27	Inotek Pharmaceuticals	MedImmune Ventures investment in Debt Financing - Inotek Pharmaceuticals	7 M USD
2013-02-06	Astria Therapeutics	MedImmune Ventures investment in Venture Round - Astria Therapeutics	9 M USD
2012-11-19	Applied Genetics Technologies Corporation	MedImmune Ventures investment in Series B - Applied Genetics Technologies Corporation	37.5 M USD
2012-11-06	Ambit Biosciences	MedImmune Ventures investment in Venture Round - Ambit Biosciences	50 M USD